Identification of variants in genes associated with hypertrophic cardiomyopathy in Mexican patients

被引:1
|
作者
Garcia-Vielma, Catalina [1 ]
Lazalde-Cordova, Luis Gerardo [1 ]
Arzola-Hernandez, Jose Cruz [2 ]
Gonzalez-Aceves, Erick Noel [2 ]
Lopez-Zertuche, Herminio [3 ]
Guzman-Delgado, Nancy Elena [2 ]
Gonzalez-Salazar, Francisco [1 ]
机构
[1] Inst Mexicano Seguro Social, Ctr Invest Biomed Noreste, Dept Citogenet, Monterrey, Mexico
[2] Inst Mexicano Seguro Social, Dr Alfonso J Trevino Trevino Ctr Med Nacl Noreste, Dept Electrofisiol, Unidad Med Alta Especial,Hosp Cardiol, Monterrey, Mexico
[3] Inst Mexicano Seguro Social, Hosp Gen Zona 4, Monterrey, Mexico
关键词
Hypertrophic cardiomyopathy; Sudden death; MYH7; MYBPC3; Gene variants; CARDIAC-ARRHYTHMIAS; MUTATION SPECTRUM; AMERICAN-COLLEGE; PREVALENCE; PHENOTYPE; TROPONIN; BINDING; COHORT; HETEROGENEITY; POPULATION;
D O I
10.1007/s00438-023-02048-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The objective of this work was to identify genetic variants in Mexican patients diagnosed with hypertrophic cardiomyopathy (HCM). According to world literature, the genes mainly involved are MHY7 and MYBPC3, although variants have been found in more than 50 genes related to heart disease and sudden death, and to our knowledge there are no studies in the Mexican population. These variants are reported and classified in the ClinVar (PubMed) database and only some of them are recognized in the Online Mendelian Information in Men (OMIM). The present study included 37 patients, with 14 sporadic cases and 6 familial cases, with a total of 21 index cases. Next-generation sequencing was performed on a predesigned panel of 168 genes associated with heart disease and sudden death. The sequencing analysis revealed twelve (57%) pathogenic or probably pathogenic variants, 9 of them were familial cases, managing to identify pathogenic variants in relatives without symptoms of the disease. At the molecular level, nine of the 12 variants (75%) were single nucleotide changes, 2 (17%) deletions, and 1 (8%) splice site alteration. The genes involved were MYH7 (25%), MYBPC3 (25%) and ACADVL, KCNE1, TNNI3, TPM1, SLC22A5, TNNT2 (8%). In conclusion; we found five variants that were not previously reported in public databases. It is important to follow up on the reclassification of variants, especially those of uncertain significance in patients with symptoms of the condition. All patients included in the study and their relatives received family genetic counseling.
引用
收藏
页码:1289 / 1299
页数:11
相关论文
共 50 条
  • [41] Predictors of Syncope in Patients with Hypertrophic Cardiomyopathy
    Haghjoo, Majid
    Faghfurian, Babak
    Taherpour, Mehdi
    Fazelifar, Amir Farjam
    Mohammadzadeh, Shabnam
    Alizadeh, Abolfath
    Sadr-Ameli, Mohammad Ali
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2009, 32 (05): : 642 - 647
  • [42] Stress Testing in Patients With Hypertrophic Cardiomyopathy
    Argulian, Edgar
    Chaudhry, Farooq A.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2012, 54 (06) : 477 - 482
  • [43] Neuromuscular disorders associated with apical hypertrophic cardiomyopathy
    Finsterer, Josef
    Stoellberger, Claudia
    ACTA CARDIOLOGICA, 2009, 64 (01) : 85 - 89
  • [44] Interdisciplinary approach to surgical treatment for patients with hypertrophic obstructive cardiomyopathy
    Rudenko, K., V
    Nevmerzhytska, L. O.
    Kozhanov, M., V
    Tregubova, M. O.
    Danchenko, P. A.
    ZAPOROZHYE MEDICAL JOURNAL, 2021, 23 (04) : 492 - 502
  • [45] Sarcomere Protein Gene Mutations in Patients With Apical Hypertrophic Cardiomyopathy
    Gruner, Christiane
    Care, Melanie
    Siminovitch, Katherine
    Moravsky, Gil
    Wigle, E. Douglas
    Woo, Anna
    Rakowski, Harry
    CIRCULATION-CARDIOVASCULAR GENETICS, 2011, 4 (03) : 288 - 295
  • [46] Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy
    Johnson, Jonathan N.
    Grifoni, Camilla
    Bos, J. Martijn
    Saber-Ayad, Maha
    Ommen, Steve R.
    Nistri, Stefano
    Cecchi, Franco
    Olivotto, Iacopo
    Ackerman, Michael J.
    EUROPEAN HEART JOURNAL, 2011, 32 (09) : 1114 - 1120
  • [47] Co-inheritance of mutations associated with arrhythmogenic cardiomyopathy and hypertrophic cardiomyopathy
    De Bortoli, Marzia
    Calore, Chiara
    Lorenzon, Alessandra
    Calore, Martina
    Poloni, Giulia
    Mazzotti, Elisa
    Rigato, Ilaria
    Marra, Martina Perazzolo
    Melacini, Paola
    Iliceto, Sabino
    Thiene, Gaetano
    Basso, Cristina
    Daliento, Luciano
    Corrado, Domenico
    Rampazzo, Alessandra
    Bauce, Barbara
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2017, 25 (10) : 1165 - 1169
  • [48] Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction
    Rowin, Ethan J.
    Maron, Barry J.
    Carrick, Richard T.
    Patel, Parth P.
    Koethe, Ben
    Wells, Sophie
    Maron, Martin S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (24) : 3033 - 3043
  • [49] Finding the candidate sequence variants for diagnosis of hypertrophic cardiomyopathy in East Slovak patients
    Zigova, Michaela
    Bernasovska, Jarmila
    Boronova, Iveta
    Blascakova, Marta Mydlarova
    Kmec, Jan
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (03)
  • [50] Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy
    Minh Thu Tran Vu
    Thuy Vy Nguyen
    Nha Van Huynh
    Hoang Tam Nguyen Thai
    Vinh Pham Nguyen
    Thuy Duong Ho Huynh
    CIRCULATION JOURNAL, 2019, 83 (09) : 1908 - +